Wu K - Search Results

1

Aloperine Suppresses Cancer Progression by Interacting with VPS4A to Inhibit Autophagosome-lysosome Fusion in NSCLC.

Guo W, Zhou H, Wang J, Lu J, Dong Y, Kang Z, Qiu X, Ouyang X, Chen Q, Li J, Cheng X, Du K, Li M, Lin Z, Jin M, Zhang L, Sarapultsev A, Shi K, Li F, Zhang G, Wu K, Rong Y, Heissmeyer V, Liu Y, Li Y, Huang K, Luo S, Hu D. Guo W, et al. Among authors: wu k. Adv Sci (Weinh). 2024 Aug;11(31):e2308307. doi: 10.1002/advs.202308307. Epub 2024 Jun 21. Adv Sci (Weinh). 2024. PMID: 39166458 Free PMC article.

2

Targeting lysosomes in human disease: from basic research to clinical applications.

Cao M, Luo X, Wu K, He X. Cao M, et al. Among authors: wu k. Signal Transduct Target Ther. 2021 Nov 8;6(1):379. doi: 10.1038/s41392-021-00778-y. Signal Transduct Target Ther. 2021. PMID: 34744168 Free PMC article. Review.

3

Defining the sensitivity landscape of EGFR variants to tyrosine kinase inhibitors.

An L, Wang Y, Wu G, Wang Z, Shi Z, Liu C, Wang C, Yi M, Niu C, Duan S, Li X, Tang W, Wu K, Chen S, Xu H. An L, et al. Among authors: wu g, wu k. Transl Res. 2023 May;255:14-25. doi: 10.1016/j.trsl.2022.11.002. Epub 2022 Nov 5. Transl Res. 2023. PMID: 36347492 Free article.

4

Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy.

Niu M, Yi M, Wu Y, Lyu L, He Q, Yang R, Zeng L, Shi J, Zhang J, Zhou P, Zhang T, Mei Q, Chu Q, Wu K. Niu M, et al. Among authors: wu y, wu k. J Hematol Oncol. 2023 Aug 12;16(1):94. doi: 10.1186/s13045-023-01487-5. J Hematol Oncol. 2023. PMID: 37573354 Free PMC article.

5

TGF-β: A novel predictor and target for anti-PD-1/PD-L1 therapy.

Yi M, Li T, Niu M, Wu Y, Zhao Z, Wu K. Yi M, et al. Among authors: wu y, wu k. Front Immunol. 2022 Dec 19;13:1061394. doi: 10.3389/fimmu.2022.1061394. eCollection 2022. Front Immunol. 2022. PMID: 36601124 Free PMC article. Review.

6

Targeting cytokine and chemokine signaling pathways for cancer therapy.

Yi M, Li T, Niu M, Zhang H, Wu Y, Wu K, Dai Z. Yi M, et al. Among authors: wu y, wu k. Signal Transduct Target Ther. 2024 Jul 22;9(1):176. doi: 10.1038/s41392-024-01868-3. Signal Transduct Target Ther. 2024. PMID: 39034318 Free PMC article. Review.

7

Unlocking the Potential of Disulfidptosis-Related LncRNAs in Lung Adenocarcinoma: A Promising Prognostic LncRNA Model for Survival and Immunotherapy Prediction.

Nie X, Ge H, Wu K, Liu R, He C. Nie X, et al. Among authors: wu k. Cancer Med. 2024 Oct;13(20):e70337. doi: 10.1002/cam4.70337. Cancer Med. 2024. PMID: 39431755 Free PMC article.

8

Focal adhesion kinase: from biological functions to therapeutic strategies.

Tan X, Yan Y, Song B, Zhu S, Mei Q, Wu K. Tan X, et al. Among authors: wu k. Exp Hematol Oncol. 2023 Sep 25;12(1):83. doi: 10.1186/s40164-023-00446-7. Exp Hematol Oncol. 2023. PMID: 37749625 Free PMC article. Review.

9

Decreased DACH1 expression in glomerulopathy is associated with disease progression and severity.

Liu QQ, Zhou YQ, Liu HQ, Qiu WH, Liu H, Hu TY, Xu Q, Lv YM, Wu KM. Liu QQ, et al. Oncotarget. 2016 Dec 27;7(52):86547-86560. doi: 10.18632/oncotarget.13470. Oncotarget. 2016. PMID: 27888806 Free PMC article.

10

Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets.

Luo XY, Wu KM, He XX. Luo XY, et al. J Exp Clin Cancer Res. 2021 May 18;40(1):172. doi: 10.1186/s13046-021-01968-w. J Exp Clin Cancer Res. 2021. PMID: 34006331 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,500 results

Search Page

Filters